LC1236
LC1236 is a thymidylate synthase (hTS) dimer dissociator with a target Kd of 7 μM and poor transmembrane permeability. LC1236 inhibits enzymatic activity by shifting the monomer-dimer equilibrium toward inactive monomers. LC1236 acts as a cytotoxic agent to inhibit cancer cell growth, and exerts synergistic cytotoxicity with electroporation via enhancing intracellular accumulation. LC1236 can be used in the research of cancers such as ovarian cancer and colorectal cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2756347-47-2
- Formule: C21H16N2O5S
- Masse moléculaire:408.43
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
LC1236 (50–100 μM; 72 h), when combined with electroporation, exhibited synergistically enhanced cytotoxicity in A2780 ovarian cancer cells, A2780/CP Cisplatin (HY-17394)-resistant ovarian cancer cells, and HCT116 colorectal adenocarcinoma cells, overcoming its intrinsic poor cell membrane permeability[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2756347-47-2
-
Masse moléculaire 408.43
-
Formule C21H16N2O5S
-
SMILES
O=C(NC1=CC=C(C(O)=O)C=C1)C(C2=CC=CC=C2)SC3=CC=C([N+]([O-])=O)C=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- LC1236
- 2756347-47-2
- LC 1236
- LC-1236
- Thymidylate Synthase
- A2780 ovarian carcinoma
- pancreatic adenocarcinoma
- A2780/CP cisplatin-resistant ovarian carcinoma
- ovarian cancer
- HCT116 colorectal adenocarcinoma
- colorectal cancer
- cisplatin-resistant gynecological cancer
- human thymidylate synthase
- Inhibitor
- inhibitor
- inhibit